Start Submission Become a Reviewer

Reading: Therapeutic Transdifferentiation: A Novel Approach for Ischemic Syndromes

Download

A- A+
Alt. Display

Review Articles

Therapeutic Transdifferentiation: A Novel Approach for Ischemic Syndromes

Authors:

Jennifer P. Connell ,

Houston Methodist Research Institute, Houston, Texas, US
About Jennifer P.
Ph.D.
X close

Santhisri Kodali,

Houston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas, US
About Santhisri
M.D.
X close

John P. Cooke

Houston Methodist Research Institute, Houston, Texas, US
About John P.
M.D., Ph.D.
X close

Abstract

The technological development of induced pluripotent stem cells (iPSCs) has overcome many of the limitations of adult and embryonic stem cells. We have found that activation of innate immunity signaling is necessary for this process, as it facilitates epigenetic plasticity in cells by a process called transflammation. More recently, we have discovered that transflammation also facilitates the transdifferentiation of cells directly from one somatic cell type to another. This insight may lead to a promising therapeutic pathway that avoids reverting cells all the way back to pluripotency before achieving a cell type of interest. While there is much therapeutic promise to transflammation and transdifferentiation, there is also evidence that transdifferentiation plays a role in some pathological conditions, including atherosclerosis. Ultimately, better understanding of transflammation will facilitate the development of regenerative therapies.

How to Cite: 1. Connell JP, Kodali S, Cooke JP. Therapeutic Transdifferentiation: A Novel Approach for Ischemic Syndromes. Methodist DeBakey Cardiovascular Journal. 2015;11(3):176-180. DOI: http://doi.org/10.14797/mdcj-11-3-176
1
Views
Published on 01 Jul 2015.
Peer Reviewed

Downloads

  • PDF (EN)